China Net Finance April 30 (Reporter Ling Wei) A "mechanical font" medical device product "Moxibustion sticker" is said to be able to treat chronic diseases such as cervical spondylosis and rheumatoid arthritis, and to regulate all sub-health in the body. It has even participated in the treatment of new coronary pneumonia many times.
Recently, China Net Finance reporters noticed that two companies, Mituomi Big Health Management Co., Ltd. (hereinafter referred to as "Mitomi Big Health Company") and Shenzhen Mituomi Biotechnology Co., Ltd. (hereinafter referred to as "Shenzhen Mituomi Company") claimed on their official website and WeChat public account that the "Mitomi" moxibustion series products have participated in the treatment of Wuhan Fangca Hospital and are suitable for a variety of chronic diseases such as cervical spondylosis, periarthritis of the shoulder, lumbar muscle strain, and stomach pain. It is understood that the manufacturer of the above-mentioned moxibustion series products is Wuhan Guojiu Technology Development Co., Ltd. (hereinafter referred to as "Wuhan Guojiu Company").
Regarding the question, the relevant person in charge of the Public Relations Department of Mituo Mi Big Health Company said in response to China Finance that the company's medical device products do have certain effects and the company has never exaggerated publicity.
promotes that its medical device products have therapeutic effects
Source: "Mitoumi" official Weibo
According to the official website link released by the official Weibo of Mitomi Health Company, the 21 products under Mitomi Health Company include 13 moxibustion series products, 4 Hengxin brand probiotic products, as well as four independent products: "Hengxin brand probiotic mask", "M2M white creatine", "Eight oysters", and "Bright eyes".
Among them, 13 moxibustion series products include "analgesic moxibustion", "low back pain moxibustion", "asthma moxibustion", "cough moxibustion", "cold moxibustion", "neck pain moxibustion", "prostate moxibustion", "diarrhea moxibustion", "kidney-strengthening moxibustion", "dysmenorrhea moxibustion", "eye-protecting moxibustion", "meridian moxibustion", and "moxibustion moxibustion".
Mitoumi Health Company claims on its official website that most of the above-mentioned moxibustion series products have therapeutic effects. For example, "Analgesic moxibustion" is suitable for cervical spondylosis, lumbar disc herniation, soft tissue damage, rheumatoid arthritis, periarthritis of the shoulder, bone hyperplasia, lumbar muscle strain, dysmenorrhea, stomachache, etc.; "Prostate moxibustion" is suitable for prostatitis, , prostate hyperplasia and other symptoms such as urination or frequent urination caused by causes such as prostatitis, , prostate hyperplasia, etc.; "Cough moxibustion" is suitable for cervical spondylosis, and the acupoints of traditional Chinese medicines that dispel wind and cold, relieve cough and phlegm and relieve cough, and is suitable for symptoms such as continuous coughing, clear and thin phlegm, thin white color, fear of wind and cold, slightly heat and no sweat, nasal congestion and runny nose caused by acute and chronic bronchitis.
reporter noticed that among the 13 moxibustion series products displayed on the official website, except for the three products "eye protection moxibustion", "meridian moxibustion" and "moxibustion acupuncture", the other 10 products are marked with medical device registration certificate numbers.
It is understood that medical device products refer to products with the "mechanical" font size approved by the national drug regulatory authorities. They refer to instruments, equipment, instruments, in vitro diagnostic reagents, calibrators, materials, and other similar or related items that are directly or indirectly used in the human body. Their utility is mainly obtained through physical means, not through pharmacology, immunology or metabolic means.
Regarding the question of "whether medical devices with physiotherapy and rehabilitation equipment can promote the treatment of chronic diseases such as prostatitis, gastritis, and hypertension", local market supervision departments have repeatedly clarified it through supervision and law enforcement, legal education, etc. For example, the Medical Device Supervision Department of Qingdao Food and Drug Administration once stated in the "Citizens' Questions" column on the official website of the local government that the specific role of medical device products should be determined based on the "Scope of Application" in its "Medical Device Product Registration Certificate". If the publicity of medical device products exceeds the scope of application of the product, it can be judged as illegal advertisements. Citizens can directly complain to the industrial and commercial department and require investigation and punishment in accordance with the law.
Source: Qingdao Government Affairs Network
The reporter searched the medical device registration certificate number "Enghe Medicine and Drug Control (Accurate) No. 22606" marked on the above products at the State Food and Drug Administration. A total of 30 related records were found, totaling 15 moxibustion series products.Click "Analgesic Moxibustion" in it. The relevant page shows that the registration certificate number is No. 2260642 of Hubei Medicine and Medical Devices (Certification) No. 2260642, which belongs to the second category of medical devices. It is valid until December 31, 2021, but the name of the registrant and the scope of application are not displayed.
Wuhan Guomoxibustion Company staff said in response to China.com Finance that the above 15 moxibustion series products are all produced by Wuhan Guomoxibustion Company.
Source: State Food and Drug Administration
The reporter searched the keyword "Wuhan National Moxibustion" on the official website of the State Food and Drug Administration. He only searched for a product with "thermal magnetic physiotherapy patch". The medical device registration certificate number also does not match the marks of the above-mentioned moxibustion series products. This product consists of a heat-producing body, a heat-relieving pad, a magnetic sheet, and affixed wing. Its scope is only "ancillary treatments used to promote local blood circulation, analgesia, reduce swelling, and promote tissue healing". It does not include symptoms such as urination caused by prostatitis, prostate hyperplasia, etc., such as frequent urination or frequent astringent pain caused by, nor does it include the effects of dispelling wind and dispelling cold, relieving phlegm and relieving cough.
Source: State Food and Drug Administration
It is worth noting that not long ago on November 8, 2019, in a batch of illegal health food advertising cases released by Wenzhou Municipal Market Supervision Bureau, Wenzhou Mituomi Trading Co., Ltd. was punished for publishing false advertisements for health foods - Ruian Municipal Market Supervision Bureau ordered Wenzhou Mituomi Company to stop publishing illegal advertisements and impose a fine of 20,800 yuan.
Although Wenzhou Mituomi Trading Co., Ltd. has no direct relationship with Mituomi Health Company in terms of equity , the product "Hengxin Brand Probiotic Powder" involved in this penalty is a product of Mituomi Health Company.
Source: Wenzhou Municipal Market Supervision and Administration Bureau
Promote a number of "moxibustion" products to participate in the treatment of temporary hospitals
Mituomi Big Health Company's official website and its official WeChat official account "Mitomi Service Account" once claimed that during the epidemic, the "Mitomi" moxibustion sticker products participated in the treatment of Wuhan temporary hospitals and had "seven-page CCTV News Broadcast".
According to the article "What impact does the new crown pneumonia epidemic have on the big health industry" released by the official website of Mituomi Big Health Company on April 17, 2020, it said that in the face of the new crown pneumonia epidemic virus, Mituomi urgently allocated about 5 million yuan of rescue and anti-epidemic materials and a series of moxibustion products (cold moxibustion, cough moxibustion, asthma moxibustion, and kidney strengthening moxibustion) to Wuhan. Many temporary hospitals in Wuhan have applied traditional Chinese medicine moxibustion and patches to patients' acupoints through external treatment methods, which are used to regulate body functions. Their good results are warmly welcomed by patients.
The article "March Brand Event (Review)" released by the WeChat public account "Mituomi Service Account" on April 2 promoted the article "Mijia National Moxibustion responded to the call as soon as possible, and urgently allocated moxibustion products into the temporary hospital, combining traditional Chinese and Western medicine to prevent and treat the new coronavirus", "Traditional Chinese medicine moxibustion therapy has significant results in the prevention and treatment of the new coronavirus this time", "Traditional Chinese medicine moxibustion, epidemic prevention and anti-epidemic" and other contents.
The aforementioned relevant person in charge of the public relations department of Mituomi Health Company said that during the epidemic, the company did donate to the temporary hospital and did appear on the news broadcast seven times. "The above-mentioned promotional content of the WeChat public account 'Mitomi Service Account' may be that there are some wrong words, and I will give feedback to relevant personnel."
Source: Mituomi Health Company official website
Source: Mituomi Health Company official WeChat public account
Source: Mituomi Health Company official WeChat public account
According to the distributor of Mituomi Big Health Company, the "moxibustion" series of products "according to acupoints, all sub-healths of the body can be conditioned, and can be used for ages 0-100. Most babies use (Hengxin) probiotic products to improve resistance."
In addition, Mituomi dealers also frequently share in their circle of friends that "'Analgesic moxibustion' cured the back pain that failed to cure when they went to the hospital for several times", "using 'Chinese moxibustion' with 3 courses of treatment, curing rhinitis for many years", "'Chinese moxibustion' and 'Hengxin probiotic' cured the second-degree meniscus damage".
In response to this, the relevant person in charge of the public relations department of Mituomi Health Company said that the company currently has about 400,000 dealers nationwide, "The company also strictly controls their publicity and cannot involve false publicity.If there is some unrealistic publicity content in their circle of friends, this is their personal behavior and has nothing to do with the company. "
The person in charge said that the company's product promotion is promoted in accordance with the Advertising Law and relevant regulations. "All product promotions on the company's official website are registered with a broad review form. Those that are not registered are daily necessities and do not belong to medical devices. "
Dealer "multi-layer rebate". The company said it was "belongs to the gray area" and "not true"
. During the investigation, the reporter called Mituomi Big Health Company as the buyer. The relevant staff said, "The company does not directly sell moxibustion products to the outside world. The sales are all authorized to dealers or agents under its name. "After that, the reporter communicated with the agent of Shenzhen Mituomi Company, and the other party said that he was a first-level dealer of Mituomi.
According to the "Purchase Price List" provided by the dealer, there are 40 boxes/box of moxibustion in China, 50 boxes/box of probiotics, and 40 boxes/box of eight oysters. If it is a dealer retail, the customer categories include "retail", "experienced packaging", "self-use packaging", and "home packaging"; if it is a dealer wholesale, the customer categories include "regional general distribution", " second-level dealer ", and "first-level dealer".
Among them, retail is to purchase 1 box, and the pickup price is to purchase 98 yuan/box; experience packaging is to purchase 3 boxes, the pickup price is to purchase 80 yuan/box, and the purchase price is to purchase 2 40 yuan; self-use packaging is to purchase 10 boxes, the pickup price is 70 yuan/box, the purchase price is 700 yuan; family packaging is to purchase 50 boxes, the pickup price is 60 yuan/box, the purchase price is 3,000 yuan.
The total sales pickup quantity is 500 boxes, each box is 45 yuan, the purchase price is 22,500 yuan, and the performance deposit is 700 yuan; the second-level dealer pickup quantity is 2,000 boxes, each box is 35 yuan, the purchase price is 70,000 yuan, and the performance deposit is 2,600 yuan; the first-level dealer pickup quantity is 6,000 yuan, and the performance deposit is 180,000 yuan.
Mituomi first-level dealer share the reporter's "Purchase Price List"
During the communication, the first-level dealer told reporters, "When the number of pickups reaches more than 100 boxes, in addition to the difference profit earned by selling the goods, they will also receive corresponding rebates. This rule is suitable for all the company's products. ”
From the other party sharing the reporter's "rebate form" it can be seen that when picking up 6,000 boxes, each box is rebate 9.5 yuan, and the unit price per box is 20.5 yuan, totaling up to 2.28 million yuan.
Regarding the "rebate", the head of the public relations department said at first that he was not very clear about the "rebate", and then said that the company does not have this problem. "The above-mentioned 'rebate' problem is in a gray area and is contrary to the national laws and regulations. I have learned a little about this question before, and the above-mentioned "rebate" situation is not true. "The person in charge said that the company's lower-level dealers include three levels: first-level, second-level, and regional-level, and dealers purchase goods through the company's accounts."
Mituomi first-level dealers share the reporter's "rebate form"
The main enterprise behind the "Mitomi" moxibustion series products
Day-day eye check shows that Mituomi Big Health Company was established on November 1, 2018 with a registered capital of 50 million yuan. The legal representative is Zhang Aimin. The company's business scope includes health consultation (excluding medical and health activities); food sales (no business activities shall be carried out without obtaining relevant administrative licenses (approvals)); Class II medical devices operation; pharmaceutical technical consultation (excluding medical and health activities), etc.
Mituomi Health Company owns multiple registered trademarks such as "Mituomi M2M", "M2M", "Miwang", "Mituomi", "MITUOMI", "Miertang", and "Mituomi".
Mituomi Da Health Management Co., Ltd. Equity penetration diagram (Source: Tianyancha)
Wuhan Guomoxibustion Company's official website shows that the company was established in 1999 and is a high-tech enterprise with national key new products. The "China Moxibustion" and "China Moxibustion" brands are natural fever-type moxibustion patches on the market. The company has opened a factory in Russia and plans to list it in the near future.
day eye check shows that the registered capital of Wuhan Guojiu Company is 50 million yuan, and Fu Jinlong is the legal representative and the major shareholder holding 79.56% of the shares.The company's business scope includes the development and development of moxibustion therapy; the research and development, production and sales of medical devices; medical and pharmaceutical consulting services; the development, development, design, production and sales of disinfection products; the purchase and sales of traditional Chinese herbal medicines (including direct oral Chinese medicinal materials (excluding national restricted varieties)); the production and sales of first, second and third categories of medical devices, etc.
Wuhan Guomoxibustion Company has 6 registered trademarks: "Moxibustion", "Light of Long Fire", "Light of Long Fire", "Family Moxibustion", "Full Fire", and "Tongtong". Relevant staff of Wuhan Guomoxibustion Company said that the "China Moxibustion" series of products promoted by Mituomi Big Health Company are produced by the company. Wuhan Guomoxibustion Company is responsible for the production and research and development of products, and Mituomi Big Health Company is responsible for the publicity and sales. ”
Wuhan Guoji Technology Development Co., Ltd. Equity penetration diagram (Source: Tianyancha)
Shenzhen Mituomi Company was established on September 25, 2015 with a registered capital of 500,000 yuan. The legal representative is Liang Qiaomei. The company's business scope includes biotechnology development; sales of disinfection supplies and daily necessities; domestic trade; import and export of goods and technology. (Except for projects prohibited by laws, administrative regulations, and the State Council decides that restricted projects must obtain a license before they can be operated) Sales of pre-packaged foods and health products; sales of third-class medical devices. It is worth noting that the business scope of Shenzhen Mituomi Company does not include Class II medical devices.
Shenzhen Mituomi Biotechnology Co., Ltd. Equity penetration diagram (Source: Tianyancha)
(Editor in charge: Niu He)
